Showing 301 - 320 results of 8,597 for search 'effective dysfunction', query time: 0.12s Refine Results
  1. 301
  2. 302

    ROLANDIC EPILEPSY OF CHILDHOOD: CORRECTION OF COGNITIVE DYSFUNCTIONS by S.V. Balkanskaya, L.M. Kuzenkova, V.M. Studenikin, O.I. Maslova

    Published 2008-10-01
    “…The paper is dedicated to the problem of cognitive dysfunctions in pediatric patients with rolandic epilepsy (benign partial epilepsy of childhood). …”
    Get full text
    Article
  3. 303

    ENDOTHELIAL DYSFUNCTION IN MEN - A CLINICAL VIEW by I. A. Khripun, Z. R. Gtisova, H. S. Ibishev, A. S. Sultanmuradova, S. V. Vorobiev, M. I. Kogan

    Published 2014-10-01
    “…Endothelial dysfunction is an early marker for the development and progression of cardiovascular diseases. …”
    Get full text
    Article
  4. 304
  5. 305

    ASSOCIATION OF DEPRESSION AND ERECTILE DYSFUNCTION IN CARDIAC PATIENTS by S. A. Pomeshkina

    Published 2012-08-01
    “…There are complex multifactorial associations between depression, coronary heart disease (CHD), and erectile dysfunction (ED). Depression is considered as an independent risk factor of CHD, as well as a strong predictor of higher risk of mortality and complications in CHD patients. …”
    Get full text
    Article
  6. 306

    The pharmacological management of erectile dysfunction – Update 2016 by André Marais

    Published 2016-08-01
    “…Erectile dysfunction (ED) is a trivial condition with a prevailing incidence worldwide. …”
    Get full text
    Article
  7. 307

    Mechanisms of Perivascular Adipose Tissue Dysfunction in Obesity by Maria S. Fernández-Alfonso, Marta Gil-Ortega, Concha F. García-Prieto, Isabel Aranguez, Mariano Ruiz-Gayo, Beatriz Somoza

    Published 2013-01-01
    “…However, in established obesity, PVAT loses its anticontractile properties by an increase of contractile, oxidative, and inflammatory factors, leading to endothelial dysfunction and vascular disease. The aim of this review is to focus on PVAT dysfunction mechanisms in obesity.…”
    Get full text
    Article
  8. 308

    The Association with Subclinical Thyroid Dysfunction and Uric Acid by Yuling Xing, Linlin Yang, Jing Liu, Huijuan Ma

    Published 2021-01-01
    “…Different types of subclinical thyroid dysfunction had varied effects on serum levels of uric acid.…”
    Get full text
    Article
  9. 309
  10. 310
  11. 311

    Relationship Between Thyroid Dysfunction and Ovarian Cancer by Justyna Gogola-Mruk, Aleksandra Sirek, Izabela Kumor, Gabriela Wojtaszek, Klaudia Roszak, Karolina Kulig, Anna Ptak

    Published 2025-06-01
    “…Moreover, we present studies that reported the relationship between hyperthyroidism and hypothyroidism and the levels of metabolic hormones in the blood and the possible effects on metabolic reprogramming in OC cells. We also report data indicating the relationship between the treatment of thyroid dysfunction and OC progression. …”
    Get full text
    Article
  12. 312
  13. 313
  14. 314

    Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis by Kosuke Kaji, Soichi Takeda, Satoshi Iwai, Norihisa Nishimura, Shinya Sato, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji

    Published 2024-11-01
    “…We used a nondiabetic metabolic dysfunction-associated steatohepatitis (MASH) model to examine the effects of imeglimin on MASH independent of its glucose-lowering action. …”
    Get full text
    Article
  15. 315

    JAK2/STAT3/HMGCS2 signaling aggravates mitochondrial dysfunction and oxidative stress in hyperuricemia-induced cardiac dysfunction by Dewei Peng, Xiaoli He, Bowen Ren, Qian Wang, Lulu Peng, Yue Jiang, Shengqi Huo, Lintong Men, Wei Shi, Pengcheng Luo, Mengyin Zhu, Cuntai Zhang, Jiagao Lv, Li Lin, Sheng Li

    Published 2025-05-01
    “…The therapeutic potential of targeting the JAK2/STAT3/HMGCS2 pathway was evaluated in hyperuricemic mice using STAT3 and JAK inhibitors to assess effects on cardiac dysfunction. Results RNA sequencing showed significant upregulation of HMGCS2 mRNA in hyperuricemic mouse cardiac tissue. …”
    Get full text
    Article
  16. 316

    ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS by M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova

    Published 2015-09-01
    “…Aim. To assess the effect of the 24-week antihypertensive therapy with fixed-dose drug combination (lisinopril plus amlodipine) on endothelial dysfunction and renal function in patients with arterial hypertension (HT) and diabetes mellitus (DM) type 2.Material and methods. 30 hypertensive patients with DM type 2 (aged 40-65 years) were included into the study. …”
    Get full text
    Article
  17. 317

    Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure by N. A. Nuritdinov, U. K. Kamilova

    Published 2020-12-01
    “…Aim. To study the effects  of spironolactone  and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure (HF).Material and methods. …”
    Get full text
    Article
  18. 318
  19. 319
  20. 320